| pubmed-article:9578814 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C0238462 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9578814 | lifeskim:mentions | umls-concept:C1880198 | lld:lifeskim |
| pubmed-article:9578814 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9578814 | pubmed:dateCreated | 1998-5-21 | lld:pubmed |
| pubmed-article:9578814 | pubmed:abstractText | Prognostic factors of sporadic or inherited medullary thyroid carcinoma (MTC) are still controversial and have been assessed in old and small series. A better knowledge of these factors would improve patient management. | lld:pubmed |
| pubmed-article:9578814 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9578814 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9578814 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9578814 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9578814 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9578814 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9578814 | pubmed:issn | 0300-0664 | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:CamposJ MJM | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:BoneuAA | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:CohenRR | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:Conte-DevolxB... | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:ModiglianiEE | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:SchlumbergerM... | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:MaesBB | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:BigorgneJ CJC | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:LeclercLL | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:DumontierPP | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:GuilhemII | lld:pubmed |
| pubmed-article:9578814 | pubmed:author | pubmed-author:CorcuffBB | lld:pubmed |
| pubmed-article:9578814 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9578814 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:9578814 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9578814 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9578814 | pubmed:pagination | 265-73 | lld:pubmed |
| pubmed-article:9578814 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:meshHeading | pubmed-meshheading:9578814-... | lld:pubmed |
| pubmed-article:9578814 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9578814 | pubmed:articleTitle | Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. | lld:pubmed |
| pubmed-article:9578814 | pubmed:affiliation | Endocrinology Department, Hopital Avicenne, Bobigny, France. | lld:pubmed |
| pubmed-article:9578814 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9578814 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9578814 | lld:pubmed |
